ICD-10 Coding for Metastatic Adenocarcinoma of Lung(C34.0, C34.11, C34.11B)
Comprehensive guide to ICD-10 coding for metastatic adenocarcinoma of the lung, including primary and secondary site coding, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Adenocarcinoma of Lung
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when the specific location within the lung is not documented. |
|
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung | Use when adenocarcinoma is confirmed in the right upper lobe. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Adenocarcinoma of Lung
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Adenocarcinoma of Lung.
Failure to document histology
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Ensure biopsy results are included in the medical record., Use checklists for documentation completeness.
Unspecified laterality
Impact
Reimbursement: May lead to lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Always document and code the specific lobe and side of lung involvement.
Incorrect sequencing of codes
Impact
Primary site not coded first when appropriate.
Mitigation
Regular audits and coder training.